Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Running Your Business

Oxford Pays $20 Million To Switch Drug Programs

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, Nov. 27, 2:13 p.m. – Oxford Health Plans Inc., Trumbull, Conn., is paying a $20 million break-up fee to shift most of its pharmacy benefits management business to Merck-Medco Managed Care L.L.C., Pittsburgh.

Merck-Medco, a subsidiary of Merck & Company Inc., a giant drug manufacturer, has won a five-year contract to handle most Oxford retail and mail-order pharmacy benefits programs starting Jan. 1, 2002.

Caremark Rx Inc., Birmingham, Ala., $20 million, has been running the mail-order program under a five-year contract signed in September 1999.

Oxford has agreed to pay a $20 million settlement to get out of the contract, Caremark says.

Caremark has “agreed to fully cooperate in the transition of Oxford’s mail order pharmacy to Merck-Medco,” Oxford says.

Caremark will continue to handle specialty drug distribution services for Oxford until September 2004.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.